| |
 |
CARICOM SUMMIT ON
CHRONIC NON-COMMUNICABLE DISEASES (CNCDs)
15 September
2007
Crowne Plaza Trinidad Hotel
Port-of-Spain, Trinidad and Tobago |
|
Stemming the Tide of
Non-Communicable Diseases
In the Caribbean |
|
ESTIMATES OF ECONOMIC BURDEN OF DIABETES
AND HYPERTENSION IN THE BAHAMAS, BARBADOS AND
JAMAICA
|
| |
|
THE BAHAMAS (2002) |
|
COST ITEM |
DIABETES |
HYPERTENSION |
|
Direct Cost* ($) |
12,560,963 |
18,942,041 |
Hospitalization
|
348,250 (2%) |
685,895 (2%) |
Clinic/Doctor's Visits
|
379,920 (2%) |
907,590 (3%) |
Drugs
|
6,625,776 (29%) |
6,060,027 (17%) |
Laboratory/Diagnostic Tests
|
5,207,017 (23%) |
11,288,528
(32%) |
|
Indirect Cost* ($) |
10,523,286 |
16,339,814 |
Mortality
|
6,136,759 (27%) |
9,809,049
(28%) |
Morbidity
|
4,386,527 (19%) |
6,530,765
(19%) |
|
Total Cost** ($) |
23,084,247 (0.43%) |
35,281,854 (0.65%) |
*
Figures in parentheses represent percentages of
the total cost for each disease condition
**
Figures in parentheses represent total costs as a
percentage of GDP
|
BARBADOS (2001) |
|
COST ITEM |
DIABETESa |
HYPERTENSION |
|
Direct Cost* (B$) |
54,740,590 |
76,791,095 |
Hospitalization
|
0 (0%) |
0 (0%) |
Clinic/Doctor's Visits
|
0 (0%) |
0 (0%) |
Drugs
|
36,113,851 (62%) |
37,054,747 (31%) |
Laboratory/Diagnostic Tests
|
18,626,739 (32%) |
39,736,348
(31%) |
|
Indirect Cost* (B$) |
3,525,069 |
43,645,733 |
Mortality
|
3,525,069 (6%) |
1,506,625
(1%) |
Morbidity
|
0 (0%) |
42,139,108
(35%) |
|
Total Cost** (B$)
Total in US$ |
58,265,659 (1.41%)
29,132,829 |
120,436,828 (2.91%)
60,218,414 |
a
Indirect cost estimate for diabetes does not
include values for morbidity costs
*
Figures in parentheses represent percentages of
the total cost for each disease condition
**
Figures in parentheses represent total costs as a
percentage of GDP
|
JAMAICA (2001) |
|
COST ITEM |
DIABETES |
HYPERTENSION |
|
Direct Cost* (J$) |
7,017,249,359 |
8,454,156,769 |
Hospitalization
|
67,464,915 (1%) |
19,541,215 (<1%) |
Clinic/Doctor's Visits
|
2,890,700 (<1%) |
11,507,200 (<1%) |
Drugs
|
5,756,265,648 (65%) |
5,535,800,467 (48%) |
Laboratory/Diagnostic Tests
|
1,190,628,096 (13%) |
2,898,306,137
(25%) |
|
Indirect Cost* (J$) |
1,869,350,533 |
3,092,035,940 |
Mortality
|
1,015,308,915 (11%) |
388,791,656
(3%) |
Morbidity
|
854,041,618 (10%) |
2,703,244,284
(23%) |
|
Total Cost** (J$)
Total in US$ |
8,886,599,892 (2.33%)
182,364,045 |
11,564,192,709
(3.02%)
236,942,186 |
|
*
Figures in parentheses represent percentages of
the total cost for each disease condition
**
Figures in parentheses represent total costs as a
percentage of GDP
|
